PROGNOSTIC STAGE IV BREAST CANCER AJCC V8
Clinical trials for PROGNOSTIC STAGE IV BREAST CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new PROGNOSTIC STAGE IV BREAST CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for PROGNOSTIC STAGE IV BREAST CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Custom-Made vaccine takes on tough breast cancer
⭐️ VACCINE ⭐️ Recruiting nowThis early-stage trial tests a personalized vaccine made from a patient's own tumor, given alone or with drugs that boost the immune system (pembrolizumab or ipilimumab). The goal is to see if the vaccine is safe and can help the immune system fight triple negative breast cancer …
Matched conditions: PROGNOSTIC STAGE IV BREAST CANCER AJCC V8
Phase: PHASE1 • Sponsor: Emory University • Aim: ⭐️ VACCINE ⭐️
Last updated May 11, 2026 20:37 UTC
-
New drug targets Hard-to-Treat cancers with specific mutations
Disease control Recruiting nowThis study tests a drug called avapritinib in people with advanced solid tumors that have spread and have specific gene changes (CKIT or PDGFRA mutations). The drug works by blocking enzymes that help cancer cells grow. The goal is to see if avapritinib can shrink or control thes…
Matched conditions: PROGNOSTIC STAGE IV BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 03:24 UTC
-
New vaccine-immunotherapy combo targets breast cancer brain metastases
Disease control Recruiting nowThis study tests a combination of a dendritic cell vaccine (which trains the immune system to attack cancer) and pembrolizumab (an immunotherapy drug) in people with breast cancer that has spread to the brain. The goal is to see if this treatment can shrink brain tumors. The stud…
Matched conditions: PROGNOSTIC STAGE IV BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Electric field device shows promise in taming advanced cancers
Disease control Recruiting nowThis early-phase study tests a wearable device that creates low-intensity electric fields (tumor treating fields) combined with either cabozantinib or a chemo-immunotherapy pair (nab-paclitaxel and atezolizumab) in people with advanced solid tumors in the abdomen or chest. The go…
Matched conditions: PROGNOSTIC STAGE IV BREAST CANCER AJCC V8
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 11, 2026 20:46 UTC
-
New hope for seniors: drug combo targets tough breast cancer
Disease control Recruiting nowThis study tests how well older adults (70+) with a certain type of advanced breast cancer tolerate a drug called abemaciclib combined with hormone therapy. Participants have already tried a similar drug that stopped working. The main goal is to track side effects and see if this…
Matched conditions: PROGNOSTIC STAGE IV BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 01, 2026 16:01 UTC
-
New hope for hard-to-treat breast cancer: drug combo targets resistance
Disease control Recruiting nowThis study tests whether adding another drug (cediranib or AZD6738) to the PARP inhibitor olaparib can shrink tumors or slow cancer growth in people with advanced BRCA-mutated breast cancer that has stopped responding to PARP inhibitors. About 60 adults with HER2-negative, BRCA-p…
Matched conditions: PROGNOSTIC STAGE IV BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 29, 2026 15:05 UTC
-
Can a hair loss drug help breast cancer patients keep their hair?
Symptom relief Recruiting nowThis study tests whether minoxidil (a hair growth drug) can reduce hair loss caused by hormone therapy in breast cancer patients. About 50 women with stage I-IV breast cancer who are on hormone therapy and have noticed hair thinning will take either a pill or apply a solution to …
Matched conditions: PROGNOSTIC STAGE IV BREAST CANCER AJCC V8
Phase: EARLY_PHASE1 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Symptom relief
Last updated May 14, 2026 12:02 UTC
-
Blood test monitoring may be as effective as scans for advanced breast cancer
Knowledge-focused Recruiting nowThis study is testing whether using simple blood tests (tumor markers) to decide when to do scans is as good as the usual approach of regular scans for people with advanced hormone receptor-positive breast cancer. About 739 participants will be randomly assigned to either blood t…
Matched conditions: PROGNOSTIC STAGE IV BREAST CANCER AJCC V8
Phase: NA • Sponsor: SWOG Cancer Research Network • Aim: Knowledge-focused
Last updated May 17, 2026 03:32 UTC
-
700 breast cancer patients enrolled to unlock secrets of CDK4/6 drugs
Knowledge-focused Recruiting nowThis study follows 700 adults with advanced or metastatic breast cancer who are taking CDK4/6 inhibitors. Researchers collect blood, tissue, and fluid samples to learn how the cancer responds and why it sometimes becomes resistant. The goal is to better predict treatment success …
Matched conditions: PROGNOSTIC STAGE IV BREAST CANCER AJCC V8
Sponsor: Roswell Park Cancer Institute • Aim: Knowledge-focused
Last updated May 17, 2026 03:23 UTC